UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Mahdist Sudan (1881-1898): Historical and Social Roots of Mahdism

Historica, 2019-06, Vol.56 (vol. 56), p.133-157

Benešová, Kateřina

2019

Link zum Volltext

Verfügbarkeit prüfen

Mahdistický Súdán (1881–1898): Historické a společenské kořeny mahdismu

Historica, 2019, Vol.XLVI (56), p.133-157

Benešová, Kateřina

2019

Link zum Volltext

Verfügbarkeit prüfen

The Real Politics of the Horn of Africa: Money, War and the Business of Power

Politologická revue, 2017-01, Vol.23 (1), p.226-230

Benešová, Kateřina

2017

Link zum Volltext

Verfügbarkeit prüfen

Bayesian Network Modelling As a New Tool in Predicting of the Early Progression of Disease in Follicular Lymphoma Patients

Blood, 2020-11, Vol.136 (Supplement 1), p.20-21

2020

Link zum Volltext

Verfügbarkeit prüfen

Destiny of Elderly Patients with Lymphoma Indicated for Autologous Stem Cell Transplantation (ASCT)

Blood, 2017-12, Vol.130, p.3289-3289

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.709-712

2021

Link zum Volltext

Verfügbarkeit prüfen

Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic

Onkologie (Olomouc), 2023-10, Vol.17 (4), p.267-272

2023

Link zum Volltext

Verfügbarkeit prüfen

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index

Neoplasma, 2022-12, Vol.69 (6), p.1466

2022

Link zum Volltext

Verfügbarkeit prüfen

Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP

EJHaem, 2020-07, Vol.1 (1), p.170-180

2020

Link zum Volltext

Verfügbarkeit prüfen

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry

Frontiers in oncology, 2022-05, Vol.12, p.874462-874462

2022

Link zum Volltext

Verfügbarkeit prüfen

Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)

Klinická onkologie, 2016, Vol.29 (4), p.295-302

2016

Link zum Volltext

Verfügbarkeit prüfen

The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)

Annals of hematology, 2020-07, Vol.99 (7), p.1583-1594

2020

Link zum Volltext

Verfügbarkeit prüfen

P1240: MICROBIOME DIVERSITY IN PATIENTS WITH LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e92993bd-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT)

Hematological oncology, 2010-12, Vol.28 (4), p.192-201

2010

Link zum Volltext

Verfügbarkeit prüfen

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas

Human molecular genetics, 2001-06, Vol.10 (12), p.1265-1273

2001

Link zum Volltext

Verfügbarkeit prüfen

Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world

European journal of haematology, 2022-08, Vol.109 (2), p.162-165

2022

Link zum Volltext

Verfügbarkeit prüfen

How Relevant Are the Control Cohorts of Clinical Trials in Patients with Newly Diagnosed DLBCL in a Daily Practice?

Blood, 2022-11, Vol.140 (Supplement 1), p.3775-3776

2022

Link zum Volltext

Verfügbarkeit prüfen

Sequencing-Based Analysis of Clonal Evolution of 25 Mantle Cell Lymphoma Patients at Diagnosis and after Failure of Standard Immunochemotherapy

Blood, 2022-11, Vol.140 (Supplement 1), p.6409-6410

2022

Link zum Volltext

Verfügbarkeit prüfen

Early Follicular Lymphoma Progression in Patients Treated with Frontline Immunochemotherapy with/without Rituximab Maintenance: Clinically Meaningful Even in Chemosensitive Individuals

Blood, 2019-11, Vol.134 (Supplement_1), p.3983-3983

2019

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic

Annals of hematology, 2023-01, Vol.102 (1), p.107-115

2023

Link zum Volltext

Verfügbarkeit prüfen

The diagnostic performance of whole-body MRI in the staging of lymphomas in adult patients compared to PET/CT and enhanced reference standard-systematic review and meta-analysis

Quantitative imaging in medicine and surgery, 2022-02, Vol.12 (2), p.1558-1584

2022

Link zum Volltext

Verfügbarkeit prüfen

The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group

Leukemia research, 2018-10, Vol.73, p.29-38

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

Leukemia & lymphoma, 2015-08, Vol.56 (8), p.2350-2356

2015

Link zum Volltext

Verfügbarkeit prüfen

The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

Annals of hematology, 2018-04, Vol.97 (4), p.669-678

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(12)
Klinická Onkologie
(4)
Annals Of Hematology
(3)
Kvasný Průmysl
(3)
Leukemia
(3)
Natural Product Communications
(3)
Hemasphere
(2)
Historica
(2)
Journal Of Cancer Research And Clinical Oncology
(2)
Leukemia & Lymphoma
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic

Mahdist Sudan (1881-1898): Historical and Social Roots of Mahdism

Mahdistický Súdán (1881–1898): Historické a společenské kořeny mahdismu

The Real Politics of the Horn of Africa: Money, War and the Business of Power

Bayesian Network Modelling As a New Tool in Predicting of the Early Progression of Disease in Follicular Lymphoma Patients

Destiny of Elderly Patients with Lymphoma Indicated for Autologous Stem Cell Transplantation (ASCT)

Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT

Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index

Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry

Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)

The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)

P1240: MICROBIOME DIVERSITY IN PATIENTS WITH LYMPHOMA

Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT)

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas

Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world

How Relevant Are the Control Cohorts of Clinical Trials in Patients with Newly Diagnosed DLBCL in a Daily Practice?

Sequencing-Based Analysis of Clonal Evolution of 25 Mantle Cell Lymphoma Patients at Diagnosis and after Failure of Standard Immunochemotherapy

Early Follicular Lymphoma Progression in Patients Treated with Frontline Immunochemotherapy with/without Rituximab Maintenance: Clinically Meaningful Even in Chemosensitive Individuals

Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic

The diagnostic performance of whole-body MRI in the staging of lymphomas in adult patients compared to PET/CT and enhanced reference standard-systematic review and meta-analysis

The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group

Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

Suchergebnisse filtern